Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07780383
Recruiting
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
Phase 1 · United States · 6 sites
Registry update: 24 Sept 2026
NCT07741721
Recruiting
Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2)
Not applicable · South Korea · 30 sites
Registry update: 23 Oct 2026
NCT07346157
Recruiting
Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
Phase 1/2 · United States · 3 sites
Registry update: 28 Sept 2026
NCT07689175
Recruiting
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Phase 2 · United States · 1 site
Registry update: 25 Aug 2026
NCT07594626
Recruiting
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Phase 1/2 · United States · 1 site
Registry update: 25 Aug 2026
NCT07758101
Recruiting
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel Disease
Phase 1 · China · 1 site
Registry update: 25 Sept 2026
NCT07431073
Recruiting
Immunotherapy Master Trial for Advanced Cancers
Phase 2 · France · 1 site
Registry update: 29 Sept 2026
NCT07428993
Recruiting
Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
Phase 2 · United States · 1 site
Registry update: 3 Nov 2026
NCT07809516
Recruiting
Pedal Pump Clinical Trial on Edema V2
Not applicable · United States · 1 site
Registry update: 9 Sept 2026
NCT07775404
Recruiting
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
Phase 3 · China, Hong Kong, Malaysia, Philippines, Thailand · 44 sites
Registry update: 1 Oct 2026
NCT07360743
Recruiting
Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels
Phase 2 · France · 5 sites
Registry update: 25 Sept 2026
NCT07579208
Recruiting
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
Phase 1 · United States · 1 site
Registry update: 25 Aug 2026
NCT07687186
Recruiting
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · China · 60 sites
Registry update: 23 Oct 2026
NCT07753993
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Phase 3 · United Arab Emirates, Argentina, Australia, Bulgaria, Brazil, Canada, Chile, China, Czechia, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Hungary, Indonesia, Israel, India, Italy, Japan, South Korea, Mexico, Malaysia, Norway, Peru, Philippines, Poland, Romania, Serbia, Sweden, Thailand, Taiwan, Ukraine, United States, Vietnam · 614 sites
Registry update: 9 Sept 2026
NCT07214376
Recruiting
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Not applicable · China, United States · 18 sites
Registry update: 20 Oct 2026
NCT07812090
Recruiting
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
Phase 2 · United States · 16 sites
Registry update: 27 Oct 2026
NCT07179809
Recruiting
Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
Not applicable · United States · 1 site
Registry update: 25 Sept 2026
NCT07746180
Recruiting
Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis
Phase 2 · China · 1 site
Registry update: 15 Sept 2026
NCT07705373
Recruiting
A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease
Not applicable · United States · 3 sites
Registry update: 24 Aug 2026
2025-524488-18-00
Recruiting
A study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder.
Phase 2 · Germany, Spain, France, Italy, Poland · 67 sites
Registry update: 21 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.